NuCana (NCNA) Return on Capital Employed Growth (3y) (2021 - 2025)
NuCana (NCNA) Return on Capital Employed Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -3,782.00 |
| 10 | NuCana | 14.94 Bn | 14.90 Bn | - | 2,416.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,416.00 |
| Sep 30, 2025 | -1,261.00 |
| Jun 30, 2025 | -34,769.00 |
| Mar 31, 2025 | -21,466.00 |
| Dec 31, 2024 | -19,610.00 |
| Sep 30, 2024 | -61,486.00 |
| Jun 30, 2024 | -47,632.00 |
| Mar 31, 2024 | -22,976.00 |
| Dec 31, 2023 | -14,266.00 |
| Sep 30, 2023 | -11,582.00 |
| Jun 30, 2023 | -7,512.00 |
| Mar 31, 2023 | -6,332.00 |
| Dec 31, 2022 | -5,197.00 |
| Sep 30, 2022 | -4,482.00 |
| Jun 30, 2022 | -4,393.00 |
| Mar 31, 2022 | -5,348.00 |
| Dec 31, 2021 | -4,305.00 |
| Sep 30, 2021 | -3,377.00 |
| Jun 30, 2021 | -1,567.00 |